Shortage reports
Actual shortage:
257 (7%)
Anticipated shortage:
3 (0%)
Avoided shortage:
11 (0%)
Resolved:
3300 (92%)
3571
Discontinuation Reports
To be discontinued:
24 (7%)
Discontinued:
342 (93%)
Reversed:
0 (0%)
366
143 (4%)
32 (11%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-AZITHROMYCIN Z | 250MG | TABLET | Resolved | 2024-09-05 | 2024-11-01 | 236867 |
| APO-AZITHROMYCIN Z | 250MG | TABLET | Resolved | 2023-04-21 | 2023-06-23 | 190002 |
| APO-AZITHROMYCIN Z | 250MG | TABLET | Resolved | 2018-05-15 | 2019-02-21 | 49481 |
| APO-AZITHROMYCIN Z | 250MG | TABLET | Resolved | 2020-01-15 | 2020-01-31 | 103362 |
| APO-AZITHROMYCIN Z | 250MG | TABLET | Resolved | 2017-03-16 | 2017-10-03 | 3083 |
| APO-AZITHROMYCIN Z | 250MG | TABLET | Resolved | 2017-11-27 | 2018-04-17 | 30799 |
| APO-AZITHROMYCIN Z | 250MG | TABLET | Resolved | 2023-12-15 | 2023-12-22 | 213573 |
| APO-AZITHROMYCIN Z | 250MG | TABLET | Resolved | 2024-08-01 | 2024-11-01 | 234280 |
| APO-BACLOFEN | 10MG | TABLET | Resolved | 2024-07-25 | 2024-08-30 | 233703 |
| APO-BACLOFEN | 10MG | TABLET | Resolved | 2023-07-13 | 2023-10-27 | 198470 |
| APO-BACLOFEN | 10MG | TABLET | Resolved | 2024-04-12 | 2024-05-24 | 225011 |
| APO-BACLOFEN | 10MG | TABLET | Resolved | 2023-06-02 | 2023-08-04 | 193620 |
| APO-BACLOFEN | 20MG | TABLET | Resolved | 2023-11-17 | 2023-12-22 | 210677 |
| APO-BACLOFEN | 10MG | TABLET | Resolved | 2020-01-08 | 2020-02-10 | 102531 |
| APO-BACLOFEN | 20MG | TABLET | Resolved | 2024-03-15 | 2024-05-24 | 222455 |
| APO-BACLOFEN | 10MG | TABLET | Resolved | 2023-11-24 | 2023-12-22 | 211499 |
| APO-BACLOFEN | 10MG | TABLET | Resolved | 2019-07-03 | 2019-07-29 | 88328 |
| APO-BACLOFEN | 10MG | TABLET | Resolved | 2024-03-08 | 2024-05-24 | 221696 |
| APO-BACLOFEN | 20MG | TABLET | Resolved | 2021-05-14 | 2021-08-03 | 139403 |
| APO-BACLOFEN | 10MG | TABLET | Resolved | 2022-01-28 | 2022-02-11 | 153777 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60288 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71342 |
| APO-BOSENTAN | 62.5MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71339 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-09-07 | 2018-10-31 | 60291 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | To be discontinued | 2018-09-07 | 2018-09-07 | 60294 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2020-11-16 | 2020-11-16 | 128438 |
| APO-BROMAZEPAM - TAB 1.5MG | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
| APO-BROMAZEPAM - TAB 3MG | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
| APO-BROMAZEPAM - TAB 6MG | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
| APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
| APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41047 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
| APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |